This company listing is no longer active
AXIC A BTA Stock Overview
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
aXichem AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr7.00 |
| 52 Week High | kr7.30 |
| 52 Week Low | kr6.11 |
| Beta | 0.32 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 20.12% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| AXIC A BTA | SE Chemicals | SE Market | |
|---|---|---|---|
| 7D | 0% | 3.3% | -0.8% |
| 1Y | n/a | 4.4% | 13.0% |
Return vs Industry: Insufficient data to determine how AXIC A BTA performed against the Swedish Chemicals industry.
Return vs Market: Insufficient data to determine how AXIC A BTA performed against the Swedish Market.
Price Volatility
| AXIC A BTA volatility | |
|---|---|
| AXIC A BTA Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 6.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.3% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: AXIC A BTA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AXIC A BTA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 6 | Torsten Helsing | https://www.axichem.com |
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.
aXichem AB Fundamentals Summary
| AXIC A BTA fundamental statistics | |
|---|---|
| Market cap | kr153.91m |
| Earnings (TTM) | -kr17.26m |
| Revenue (TTM) | kr5.01m |
30.7x
P/S Ratio-8.9x
P/E RatioIs AXIC A BTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AXIC A BTA income statement (TTM) | |
|---|---|
| Revenue | kr5.01m |
| Cost of Revenue | kr1.19m |
| Gross Profit | kr3.82m |
| Other Expenses | kr21.08m |
| Earnings | -kr17.26m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
May 24, 2023
| Earnings per share (EPS) | -0.80 |
| Gross Margin | 76.25% |
| Net Profit Margin | -344.66% |
| Debt/Equity Ratio | 46.5% |
How did AXIC A BTA perform over the long term?
See historical performance and comparison